Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

C3.ai tumbles 20% on weak forecast; Wedbush sees a buying opportunity

Published 05/31/2023, 05:18 PM
Updated 06/01/2023, 09:06 AM
© Reuters.

Investing.com -- C3.ai (NYSE:AI) shares traded 20% lower in pre-market after the AI software firm offered weaker-than-expected guidance.

The company also reported fiscal fourth-quarter results Wednesday that were better than feared as growing demand for enterprise AI applications bolstered new business wins.

The AI software maker reported an adjusted loss of $0.13 on revenue of $72.4 million, topping estimates for a loss of $0.17 on revenue of $71.29M.

The better-than-feared loss for the quarter comes as increasing market demand for enterprise AI led to a "substantial increase in opportunities and shorter sales cycles," the company said.

In Q4, the company closed 43 agreements, including 19 pilots, with the number of qualified enterprise opportunities targeted for closure within 12 months in its sales pipeline more than doubling in the past year. The average sales cycle for agreements in Q4 was 3.7 months, down from 5 months a year earlier.

Looking ahead to fiscal 2024, the company now expects an adjusted loss in a range of $50.0M to $75.0M on revenue of $295.0 to $320.0M. Analysts were looking for $317M in full-year sales.

For fiscal Q1, adjusted losses from operations were guided in a range of $25.0M to $30M on revenue of between $70M to $72.5M. Analysts were forecasting Q1 revenue of $71.6M.

Following the FQ4 earnings report, the AI stock earned both a downgrade and an upgrade. DA Davidson analysts cut the rating to Neutral from Buy following the recent run-up in shares. C3.ai stock is up more than 200% year to date, riding strong investor demand for artificial intelligence-linked stocks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We believe C3.ai is on track for 2H24 acceleration based on momentum driven by generative AI demand, which is now more properly reflected in the share price," they wrote in a note.

On the other hand, Wedbush analysts upgraded the stock to Outperform from Neutral with the price target more than doubled to $50 per share.

"While it will be a bumpy road, we believe c3 has turned a corner and is ready to now capitalize on the $800 billion AI transformational opportunity over the next decade with use cases increasing across the board and the company in a unique position to help lead the charge and monetize this looking ahead the next 12 to 18 months," they said.

(Additional reporting by Senad Karaahmetovic)

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.